Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CEACAM7 expression contributes to early events of pancreatic cancer

Journal of Advanced Research(2023)10.1016/j.jare.2023.02.013Source: DataRank Database

CEACAM7 expression contributes to early events of pancreatic cancer is a research paper published in Journal of Advanced Research (2023). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

Linked data & code

bioproject uniprot doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 2.63)OA: goldTopics (51)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Swati Dhasmana,Sudhir Kotnala ORCID,Partha Laskar ORCID,Sheema Khan ORCID,Shafiul Haque ORCID

Live enrichment

PubMed:36828119 PMC:PMC10770095 OpenAlex:https://openalex.org/W4321602050

NCI NIH HHS

Grant: R01 CA204552

NCI NIH HHS

Grant: R01 CA206069

NIGMS NIH HHS

Grant: SC1 GM139727

NCI NIH HHS

Grant: R01 CA210192

National Institutes of Health

Grant: 5SC1GM139727-02

miR-205 Nanoparticle system circumvents docetaxel resistance in prostate cancer

National Institutes of Health

Grant: 7R01CA210192-05

Targeted Nanotherapy for Pancreatic Cancer

National Institutes of Health

Grant: 1R01CA206069-01A1

Development of Targeted Nanotechnology Platform for Pancreatic Cancer

National Institutes of Health

Grant: 5R01CA204552-03

MUC13 Mucin in Colorectal Cancer Health Disparity

FWCI

2.63

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://ars.els-cdn.com/content/image/1-s2.0-S2090123223000644-ga1_lrg.jpg

publisherhttps://ars.els-cdn.com/content/image/1-s2.0-S2090123223000644-ga1_lrg.jpg

publisherhttps://api.elsevier.com/content/article/PII:S2090123223000644?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2090123223000644?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jare.2023.02.013

Fields of Study

Radiopharmaceutical Chemistry and ApplicationsCancer, Stress, Anesthesia, and Immune ResponseProstate Cancer Treatment and Research0301 basic medicine0303 health sciences03 medical and health sciencesHumansBiomarkers, TumorPancreatic NeoplasmsCarcinoma, Pancreatic DuctalPrognosisCell Adhesion MoleculesCarcinoembryonic AntigenGPI-Linked Proteins

MeSH Terms

Carcinoembryonic AntigenHumansPancreatic NeoplasmsPrognosisBiomarkers, TumorCell Adhesion MoleculesCarcinoma, Pancreatic DuctalGPI-Linked Proteins

Keywords

Pancreatic cancerCancerPancaCancer researchBiomarkerOncologyMedicineInternal medicineImmunohistochemistryCarcinoembryonic antigenBiologyDiseasePdacCeacam7Early Detection BiomarkerTumor Grading & BioinformaticsMedicine (General)Science (General)PrognosisGPI-Linked ProteinsPancreatic NeoplasmsTumor grading & bioinformaticsQ1-390R5-920Biomarkers, TumorHumansOriginal ArticleCell Adhesion MoleculesCarcinoma, Pancreatic Ductal

Sustainable Development Goals

SDG 0: Good health and well-being

CEACAM7 expression contributes to early events of pancreatic cancer

FAIR Checklist

Authors (9)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)